Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women

BMC Pregnancy and Childbirth

Volumn 12, Issue , 2012, Pages

  Ezechi, Oliver C ^a   David, Agatha N ^a   Gab Okafor, Chidinma V ^a   Ohwodo, Harry ^a   Oladele, David A ^a   Kalejaiye, Olufunto O ^a   Ezeobi, Paschal M ^a   Gbajabiamila, Titilola A ^a   Adu, Rosemary A ^a   Oke, Bamidele ^a   Musa, Zaidat A ^a   Ekama, Sabdat O ^a   Ilesanmi, Oluwafunke ^a   Odubela, Olutosin ^a   Somefun, Esther O ^a   Herbertson, Ebiere C ^a   Onwujekwe, Dan I ^a   Ujah, Innocent A O ^a  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

CD4 count; Low birth weight; Pregnancy; Spontaneous preterm birth delivery HIV; Viral load

Indexed keywords

LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; ZIDOVUDINE;

ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; DATA BASE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MEDICAL ETHICS; MULTIPLE PREGNANCY; NIGERIA; OPPORTUNISTIC INFECTION; PREMATURE LABOR; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOCIOBIOLOGY; THIRD TRIMESTER PREGNANCY; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIRHEUMATIC AGENTS; FEMALE; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; NIGERIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREMATURE BIRTH; RETROSPECTIVE STUDIES; RISK FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84865808532     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-12-93     Document Type: Article

References (27)

1. Simmons LE, Rubens CE, Darmstadt GL, Gravett MG. Preventing Preterm Birth and Neonatal Mortality: Exploring the Epidemiology, Causes, and Interventions. Semin Perinatol 2010, 34(6):408-415. 10.1053/j.semperi.2010.09.005, 21094415.
2. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: When? Where? Why?. Lancet 2005, 365:891-900. 10.1016/S0140-6736(05)71048-5, 15752534.
3. Rajaratnam JK, Marcus JR, Flaxman AD, Wang H, Levin-Recto A, Dwyer L, Costa M, Lopez AD, Murray CJL. Neonatal, post neonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet 2010, 375:1988-2008. 10.1016/S0140-6736(10)60703-9, 20546887.
4. Cousens S, Stanton C, Blencowe H, et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet 2011,
5. Feresu SA, Harlow SD, Welch K, Gillespie BW. Incidence of stillbirth and perinatal mortality and their associated factors among women delivering at Harare Maternity Hospital, Zimbabwe: a cross-sectional retrospective analysis. BMC Pregnancy Childbirth 2005, 5:9. 10.1186/1471-2393-5-9, 1156907, 15876345.
6. Etuk SJ, Etuk IS, Oyo-Ita AE. Factors influencing the incidence of pre-term birth in Calabar, Nigeria. Nigerian Journal Of Physiological Sciences 2005, 20(1-2):63-68.
7. Chike-Obi U. Preterm delivery in Ilorin: multiple and teenage pregnancies as major aetiological factors. West Afr J Med 1993, 12(4):228-230.
8. Mokuolu AO, Abdul IF, Adesiyun O. Maternal factors associated with early spontaneous singleton preterm delivery in Nigeria. Trop J Obstet Gynaecol 2002, 19:32-35.
9. NACA Update on the HIV/AIDS epidemic and response in Nigeria. National Agency for Control of AIDS 2011, Abuja Nigeria, http://naca.gov.ng/content/view/423/lang,en/, NACA.
10. WHO Towards the elimination of mother-to -child transmiss ion of HIV. Report of a WHO technical consultation 2011, WHO, Geneva, http://www.who.int/hiv/pub/mtct/elimination_report/en/index.html, WHO.
11. Afe AJ, Adewum N, Emokpa A, Fagorala T, Disu AE, Ganikale I, Audu R. Outcome of PMTCT services and factors affecting vertical transmission of HIV infection in Lagos, Nigeria. HIV & AIDS Review 2011, 10(1):14-18. 10.1016/j.hivar.2011.02.001, 22977162.
12. Ezechi OC, Makinde ON, Kalu BEK, Nnatu SNN. Risk factors for preterm delivery in South Western Nigeria. J Obstet Gynaecol 2003, 23(4):387-391. 10.1080/0144361031000119556, 12881078.
13. Taguebue J, Monebenimp F, Zingg W, Mve Koh V, Atchoumi A, Gervaix A, Tetanye E. Risk Factors for Prematurity among Neonates from HIV Positive Mothers in Cameroon. World Journal of AIDS 2011, 1:1-7.
14. Bulterys M, Chao A, Munyemana S, Kurawige JB, Naw-rocki P, Habimana P, et al. Maternal human immunodeficiency virus 1 infection and intrauterine growth: a pro- spective cohort study in Butare, Rwanda. Pediatr Infect Dis J 1994, 13(2):94-100. 10.1097/00006454-199402000-00003, 8190558.
15. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1994, 105(8):836-848.
16. Olusanya O, Okpere E, Ezimokhai M. The importance of social class in voluntary fertility control in a developing country. West Afr J Med 1985, 4:205-211.
17. Dreyfuss ML, Msamanga GI, Spiegelman D, Hunter DJ, Urassa EJ, Hertzmark E, et al. Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am J Clin Nutr 2001, 74(6)):814-826.
18. Castetbon K, Ladner J, Leroy V, Chauliac M, Karita E, De Clercq A, et al. Low birth weight in infants born to African HIV-infected women: relationship with maternal body weight during pregnancy: Pregnancy and HIV Study Group (EGE). J Trop Pediatr 1999, 45(3):152-157. 10.1093/tropej/45.3.152, 10401193.
19. Townsend CL, Cortina-Boria M, Peckham CS, Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007, 21:1019-1026. 10.1097/QAD.0b013e328133884b, 17457096.
20. European Collaborative Study Swiss Mother and Child Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000, 14:2913-2920. European Collaborative Study.
21. European Collaborative Study Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV infected women. J Acquir Immune Defic Syndr 2003, 32:380-387. European Collaborative Study.
22. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?. J Infect Dis 2006, 193:195-201.
23. Powis KM, Kitch D, Ogwu A, Hughes MD, Lockman S, Leidner J, et al. Increased Risk of Preterm Delivery Among HIV Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During Pregnancy. J Infect Dis 2011, 204:506-514. 10.1093/infdis/jir307, 3144169, 21791651.
24. Szyld E, Warley EM, Freimanis L, et al. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS 2006, 20:2345-2353. 10.1097/01.aids.0000253362.01696.9d, 17117021.
25. Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta analysis. AIDS 2007, 21:607-615. 10.1097/QAD.0b013e32802ef2f6, 17314523.
26. Patel K, Shapiro DE, Brogly SB, et al. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. JID 2010, 201:1035-1044. 10.1086/651232, 2946359, 20196654.
27. Ezechi OC, Fasubaa OB, Kalu BKE, Nwokoro CA, Obiesie LO. Caesarean Delivery: Why the aversion. Trop J Obstet Gynaecol 2004, 21(2):164-167.